MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Parkinson’s disease-specific cortical atrophy as an independent contributor to motor symptom in Parkinson’s disease

    SW. Kang, HS. Yoo, CL. Lyoo (Seoul, Republic of Korea)

    Objective: In this study, we identified specific pattern of cortical atrophy in Parkinson's disease (PD) and investigated whether PD-specific cortical atrophy contributed to motor symptom,…
  • 2023 International Congress

    Clinical accuracy of Medtronic’s Percept built in longevity estimate algorithm following device exchange.

    E. Hargreaves, D. Caputo, D. Dolce, R. Dipaola, S. Danish (Neptune, USA)

    Objective: To examine the accuracy of Medtronic’s Percept built in device longevity estimate. Background: In June of 2020 Medtronic received FDA approval for its Percept…
  • 2023 International Congress

    Clinical usefulness of tandem gait test for estimating gait and balance in de novo Parkinson’s disease

    JS. Park, HT. Kim, SH. Lim (Busan, Republic of Korea)

    Objective: The purpose of this study is to objectively evaluate the gait and balance in patients with Parkinson’s disease showing abnormal tandem gait, using three-dimensional motion analysis.…
  • 2023 International Congress

    Modeling Parkinson’s disease progression accounting for the effect of symptomatic treatments in the Parkinson’s Progression Markers Initiative study

    B. Ribba, T. Simuni, K. Marek, A. Siderowf, L. Chahine, C. Diack, A. Monnet, B. Ricci, T. Nikolcheva, G. Pagano (Basel, Switzerland)

    Objective: To explore the natural history of Parkinson’s disease (PD) accounting for the effect of symptomatic treatments on progression by modeling the time course of…
  • 2023 International Congress

    Anle138b-P1-02: A randomised, double-blinded, placebo-controlled phase 1b study to investigate safety, tolerability, pharmacokinetics and pharmacodynamics of the oligomer modulator anle138b in Parkinson´s disease

    J. Levin, N. Singh, S. Melbourne, A. Morgan, C. Carroll, U. Fietzek, S. Ryazanov, A. Leonov, CH. Griesinger, F. Schmidt, D. Weckbecker, K. Prager, T. Matthias, A. Giese (Wendelsheim, Germany)

    Objective: To present first-in-patient data of the oligomer modulator anle138b (TEV-56286, emrusolmin) in patients with Parkinson’s disease (PD). Background: Synucleinopathies such as PD and Multiple…
  • 2023 International Congress

    Clinical characteristics of patients with dementia with Lewy bodies followed in a movement disorder clinic

    AS. Jakobsson, L. Salvesen, AM. Hejl (Copenhagen, Denmark)

    Objective: To describe the clinical phenotype of the subgroup of patients with Dementia with Lewy bodies (DLB) followed in a movement disorder setting rather than…
  • 2023 International Congress

    Asymmetry and the development of phase-specific deep brain stimulation for essential tremor

    S. He, A. Deli, T. West, F. Plazas, A. Pogosyan, C. Wiest, D. Herz, P. Andrade, V. Visser-Vandewalle, E. Pereira, A. Green, H. Tan, H. Cagnan (Oxford, United Kingdom)

    Objective: The main aim of the study was to investigate asymmetry in ET and the association between tremor asymmetry and the effect of DBS on…
  • 2023 International Congress

    Identification of a Metabolic Brain Pattern Specific to Corticobasal Degeneration and Its Utility in Differential Diagnosis

    T. Rus, J. Jamšek, M. Perovnik, M. Trošt (Ljubljana, Slovenia)

    Objective: To identify a metabolic brain pattern specific to corticobasal degeneration (CBD) and to develop a machine learning algorithm that can differentiate CBD from other…
  • 2023 International Congress

    Clinical and radiological factors associated with mortality in Parkinson’s disease

    G. Martí-Andrés, E. Prieto-Azcárate, CA. Espinoza-Vinces, M. Riverol, J. Arbizu, R. Luquin (Pamplona, Spain)

    Objective: To assess clinical and radiological risk factors of mortality in a cohort of patients with a clinical diagnosis of Parkinson’s disease (PD) according to…
  • 2023 International Congress

    Polyneuropathy in Parkinson’s disease: cross-sectional analysis of the Bochum Parkinson Nerve Study cohort

    R. Scherbaum, L. Basner, L. Ortmann, J. Steininger, K. Müller, A. Bieber, P. Schülken, J. Motte, A. Fisse, T. Grüter, R. Gold, K. Pitarokoili, L. Tönges (Bochum, Germany)

    Objective: To describe the prevalence of large-fiber polyneuropathy (PNP) in people with PD and examine differences between subjects with or without PNP. Background: Non-motor symptoms…
  • « Previous Page
  • 1
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley